Table 1 Positivity rate of eosinophilia, ELISA and ICT serology, and UCP-LF CAA at baseline and at follow-up time points
| Â | Confirmed infection | Possible infection | ||||
|---|---|---|---|---|---|---|
Time point | N tested | N positive | % (95% CI) | N tested | N positive | % (95% CI) |
Eosinophilia | ||||||
 T0 | 23 | 10 | 43.5 (23.2–65.5) | 25 | 2 | 8.0 (0.0–18.6) |
 T6 | 16 | 3 | 18.8 (0.0–37.8) | 23 | 1 | 4.4 (0.0–12.6) |
 T12 | 20 | 0 | 0.0 (0.0–0.0) | 17 | 0 | 0.0 (0.0–0.0) |
ELISA serology | ||||||
 T0 | 23 | 19 | 82.6 (61.2–95.1) | 25 | 14 | 56.0 (40.8–79.2) |
 T6 | 22 | 17 | 77.3 (59.7–94.8) | 21 | 14 | 66.7 (46.5–86.8) |
 T12 | 20 | 14 | 70.0 (46.5–86.8) | 16 | 7 | 43.8 (21.4–71.9) |
ICT serology | ||||||
 T0 | 18 | 18 | 100 (100–100) | 25 | 25 | 100 (100–100) |
 T6 | 19 | 18 | 94.8 (88.3–100) | 23 | 22 | 95.7 (87.4–100) |
 T12 | 20 | 19 | 95.0 (85.5–100) | 18 | 16 | 88.9 (74.4–100) |
UCP-LF CAA | ||||||
 T0 | 23 | 20 | 86.9 (66.4–97.2) | 25 | 5 | 20.0 (4.3–35.7) |
 T6 | 23 | 6 | 26.1 (7.5–44.7) | 24 | 0 | 0.0 (0.0–0.0) |
 T12 | 21 | 2 | 9.5 (0.0–21.8) | 19 | 0 | 0.0 (0.0–0.0) |